Novel 17beta hydroxysteroid dehydrogenase type I inhibitors

Details for Australian Patent Application No. 2004289459 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Thole, Heinrich-Hubert; Koskimies, Pasi; Schneider, Gyula; Johansson, Nina; Husen, Bettina; Van Steen, Bartholomeus Johannes; Adamski, Jerzy; Hulshof, Johannes Bernardus Everardus; Messinger, Josef

Agent Watermark

Pub. Number AU-B-2004289459

PCT Pub. Number WO2005/047303

Priority 03104169.2 12.11.03 EP; 04105313.3 26.10.04 EP

Filing date 11 November 2004

Wipo publication date 26 May 2005

Acceptance publication date 19 August 2010

International Classifications

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61P 5/30 (2006.01) Drugs for disorders of the endocrine system

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/047303 Priority application(s): WO2005/047303

19 August 2010 Application Accepted

  Published as AU-B-2004289459

16 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289485-Stabilisation of trans1,2-dichloroethylene

2004289447-Thiazole and pyrazole derivatives as Flt-3 kinase inhibitors